Deep Tech Startups

enclaive provides a multi-cloud platform for Confidential Computing, using hardware-based Trusted Execution Environments to keep applications, databases, and AI workloads encrypted in use so that only the customer holds the keys. It serves security-first organizations in regulated sectors that require strong data protection and sovereignty.

3 investors

General Intuition develops foundation models capable of perceiving, predicting, and acting in the physical world, trained on large-scale gameplay data to power autonomous driving, robotics, and real-world AI applications.

3 investors

Enflow develops technology to produce sulfide-based solid electrolytes in fine spherical form, researching, developing, and manufacturing materials for next-generation batteries alongside domestic partner companies. The company focuses on advanced battery materials in South Korea.

3 investors

Enki provides commercial intelligence on emerging technologies and critical infrastructure sectors including ammonia in maritime, solid oxide fuel cells, direct air capture, and nuclear power. The platform delivers cited, sourced market analysis and cost comparisons for niche markets where traditional analyst coverage is limited.

3 investors

EnsiliTech develops ensilication technology, a silica-based method to stabilise vaccines and biopharmaceuticals so they can be stored and transported without refrigeration. The company serves the pharmaceutical and biotech industry and originated from research at the University of Bath.

3 investors

Enumera Molecular develops technology and a platform for simplified, lower-cost workflows that enable liquid biopsy and high-dimensional omics assays for laboratories. It targets clinical labs performing molecular diagnostics.

3 investors

ENVGO builds electric-propulsion marine technology that lifts vessels above the water to improve efficiency and adds autonomy, real-time awareness, and safety systems for defence, transportation, and recreational markets. The Canada-based company applies aerospace, robotics, AI, and EV engineering to boats.

3 investors

Epigenic Therapeutics develops gene regulation-based biotherapeutics using its EPIREG platform, which applies AI algorithms to design CRISPR-Cas components that regulate target gene expression without altering the DNA sequence. Combined with a lipid nanoparticle delivery system, the technology targets metabolic, cardiovascular, viral hepatitis, ocular, oncology and rare diseases.

3 investors

Epyr develops thermal energy storage solutions for industrial heat electrification, enabling industries to decarbonize and adopt renewable energy. The company serves industrial customers seeking to reduce carbon emissions through practical, scalable electrification.

3 investors

E-SOL, Inc. develops laser-based and metrology solutions for EUV lithography, including High Harmonic Generation (HHG) EUV sources. The company serves chip makers with expertise in laser, optics, and system engineering.

3 investors

Espervita Therapeutics develops metabolic reprogramming therapies targeting liver and kidney disease, with a lead program in acetyl-CoA metabolic enzyme inhibitors. The company focuses on treating progressive metabolic liver diseases and related conditions.

3 investors

Esphera designs transgenes that enable budding exosomes to carry multimeric proteins for therapeutic applications, with initial focus on modifying tumor-derived exosomes to create immunostimulatory cancer vaccines.

3 investors

The company manufactures electromechanical products including rotary clutches, linear brakes, and voltage drivers for industrial applications.

3 investors

Eternis.ai is an AI research company building systems for forecasting, simulation, and calibrated prediction, including multi-agent decision-making tools for capital allocators, strategists, and forecasters. It also develops privacy-focused AI products that let users run models locally or in trusted execution environments so data stays under their control.

3 investors

Evodia is a Danish aroma company that uses precision fermentation with proprietary yeast strains to produce monoterpenes, the natural molecules behind flavor and aroma, as a sustainable alternative to plant-derived ingredients. Its Yops product provides customizable aroma blends for brewers, positioned as an alternative to hops in non-alcoholic and alcohol-free beer.

3 investors

Evok Innovations is a venture capital firm that invests in early- to mid-stage companies developing hard-tech solutions for heavy industry, including energy, mining, minerals, and industrial optimization. The firm focuses on proven technologies with clear cost advantages targeting industrial markets in Canada and the USA.

3 investors

ExeVir develops multi-specific VHH antibody therapies to treat infectious diseases, immunological conditions, and oncology, with a focus on immunocompromised populations. The company operates as a clinical-stage biotech firm leveraging a modular antibody platform to accelerate drug development.

3 investors

Experiment runs a crowdfunding platform where citizens pledge money to fund scientific research projects, giving researchers an alternative to traditional grant writing. Scientists use it to raise funding and share results with backers through lab notes and peer-reviewed publications.

3 investors

Eywa is a team of scientists and innovators focused on advancing mental health through research and partnerships.

3 investors

Farmdar builds geospatial and machine-learning tools for agriculture, using data and field operations to monitor crops and farmland. It serves agricultural clients and operates across markets including South Asia and Southeast Asia.

3 investors

Farther Farms develops technology to make shelf-stable versions of traditionally frozen or refrigerated foods, allowing distribution without cold-chain infrastructure. Its first product is a fresh-cut style, shelf-stable French fry aimed at food service globally.

3 investors

Feldan is a clinical-stage biotech company developing intracellular delivery technologies for therapeutic treatment of diseases. The company specializes in its Feldan Shuttle peptide-based technology to deliver antisense oligonucleotides and other therapeutics to cellular targets, with current programs targeting basal cell carcinoma and respiratory diseases.

3 investors

Femtum builds turn-key mid-infrared fiber laser systems that operate without requiring laser experts, serving industrial manufacturers and scientific teams for applications such as selective laser microprocessing and mid-IR spectroscopy. A Canadian spin-off from the Center of optics, photonics and laser (COPL) in Quebec City, it targets manufacturing bottlenecks in the semiconductor industry.

3 investors

The company develops AI models that let robots perform physical tasks—such as grasping, handover, and navigation—in unstructured real-world environments, exposed to users through an API for building robot applications. Its technology, referred to as the Skild Brain, targets uses like automating inspections in dangerous settings and repetitive dexterous tasks.

3 investors